Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial

Cooper, David A.

Cordery, Damien V.

Zajdenverg, Roberto

Ruxrungtham, Kiat

Arastéh, Keikawus

Bergmann, Frank

Andrade Neto, José L. de

Scherer, Joseph

Chaves, Ricardo L.

Robinson, Patrick

Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc/4.0/